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Ivermectin (IVM) has been in operational use for the control of onchocerciasis for two decades and
remains the only drug of choice. To investigate the parasitological responses and genetic proﬁle of
Onchocerca volvulus, we carried out a 21 month epidemiological study to determine the response of
the parasite to IVM in 10 Ghanaian endemic communities. Onchocerca nodules were surgically removed
from patients in three IVM response categories (good, intermediate and poor) and one IVM naïve com-
munity. DNA from adult worms was analyzed to determine any association between genotype and
IVM response phenotypic. Embryogramme analysis showed signiﬁcantly higher reproductive activity
in worms from poor response communities, which had up to 41% of females with live stretched micro-
ﬁlaria (mf) in utero, despite IVM treatment, compared with good response communities, which had no
intra-uterine stretched mf.
b-tubulin isotype 1 gene has been shown to be linked to IVM selection in O. volvulus and also known to
be associated with IVM resistance in veterinary nematodes. We have genotyped the full length genomic
DNA sequence of the b-tubulin gene from 127 adult worms obtained from the four community catego-
ries. We found SNPs at 24 sites over the entire 3696 bp. Eight of the SNPs occurred at signiﬁcantly higher
(p < 0.05) frequencies in the poor response communities compared with the good response communities
and the IVM naïve community. Phenotypic and genotypic analyses show that IVM resistance has been
selected and the genotype (1183GG/1188CC/1308TT/1545GG) was strongly associated with the resis-
tance phenotype. Since the region in the b-tubulin gene where these four SNPs occur is within 362 bp,
it is feasible to develop a genetic marker for the early detection of IVM resistance.
 2012 Australian Society for Parasitology Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Over the past two decades, ivermectin (IVM) has been central to
the control of human onchocerciasis through self-sustainable com-
munity-based treatment. IVM, taken as a single annual dose, mark-
edly suppresses onchocercal disease, reduces skinmicroﬁlarial (mf)
loads and maintains them at very low levels for 9–12 months
(Awadzi et al., 1989; Brown and Neu, 1990; Kläger et al., 1996;
Abiose, 1998; Brieger et al., 1998). This has the effect of reducing
morbidity and suppressing transmission for most of the year.
Though IVM does not kill signiﬁcant numbers of the adult worm,Published by Elsevier Ltd.
asitology, McGill University,
nada H9X3V9. Tel.: +1 514
hard).
Open acit has been demonstrated that treatment with repeated standard
doses (150 lg/kg) markedly impairs female worm fecundity and
reduces the life span of adult worms (Duke et al., 1990; Chavasse
et al., 1992; Plaisier et al., 1995). IVM resistance is a growing
problem in the livestock industry. Until recently, there was no
unequivocal evidence that resistance to IVM in Onchocerca volvulus
populations existed (Prichard, 2005), but the possibility for IVM
resistance to develop in O. volvulus was a concern due to the speed
with which IVM resistance developed in other nematodes. For
example, IVM was introduced to South Africa for the control of
veterinary parasites in the middle 1980s and within 33 months,
IVM resistance was detected (Shoop, 1993). However, it should be
noted that treatment frequencies had been very high in this in-
stance and the species of parasite was Haemonchus contortus.
Large numbers of individuals in Africa have taken IVM annually
for up to 20 years, withmillions of doses of IVM being administered
(Basáñez et al., 2006). This is likely to impose enormous selectioncess under CC BY-NC-ND license.
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Boussinesq and Gardon (1999) and Grant (2000) have suggested the
possibility of parasitological unresponsiveness to IVM treatment or
selection for drug resistance inO. volvulus. The latter author has sug-
gested that IVM resistance in O. volvulus may be manifested in the
adult parasites, leading to adult femaleworms regaining their fertil-
ity after IVM treatment sooner and repopulating the skin more
rapidly than would occur in a susceptible population and that the
consequences of this manifestation of resistance may be more
serious than a loss in microﬁlaricidal effect. Recent clinico-
parasitological studies have shown sub-optimal responses to IVM
treatment in some onchocerciasis patients in Sudan and Ghana
(Ali et al., 2002; Awadzi et al., 2004a,b). Ali et al. speculated that
the sub-optimal responses, observed in Sudan, were possibly due
to host immunocompetence. On the other hand, Awadzi et al. inves-
tigated host, pharmaceutical and parasite parameters and
concluded that the sub-optimal responses, they observed in Ghana,
were due to the development of tolerance or the selection for resis-
tance to IVM in the adult female worms.
b-tubulin, a protein component of microtubules, has been
linked to IVM selection and resistance in parasitic nematodes.
Freeman et al. (2003) compared the amphid structures of IVM sen-
sitive and resistant strains of H. contortus, and found a signiﬁcant
shortening and diffused morphology of the amphidial dendrites,
most notably with a marked loss of microtubule bundles, in IVM
resistant strains. Mottier and Prichard (2008), reported IVM selec-
tion on b-tubulin isotype 1 in a large number of H. contortus iso-
lates resistant to IVM. They found two single nucleotide
polymorphisms (SNPs) causing amino acid changes from phenylal-
anine to tyrosine, at codons 167 and 200, in b-tubulin isotype 1
gene that were associated with IVM selection and resistance in
H. contortus. This selection was observed in strains that had not
been subject to benzimidazole selection. Eng and Prichard (2005)
and Eng et al. (2006) showed signiﬁcant changes in allele frequen-
cies of b-tubulin isotype 1 gene in O. volvulus exposed to repeated
rounds of IVM treatment. Bourguinat et al. (2007) have also re-
ported that IVM causes genetic selection on the b-tubulin gene in
O. volvulus worms, with the most marked effect on selection being
associated with a lower reproductive rate of the female parasites.
In veterinary parasites, anthelmintic resistance is usually ﬁrst
suspected when animals fail to respond to treatment. In O. volvulus,
the response to treatment relies on the parasitological measures of
IVM effectiveness, namely the rate of skin microﬁlarial clearance,
repopulation of the skin by microﬁlariae after treatment, assess-
ment of female worm fertility, via embryogrammes, and the pres-
ence of infective stages in blackﬂy vectors following years of IVM
control. We have previously reported parasitological and epidemi-
ological evidence of emerging IVM resistance in O. volvulus,
expressed in adult populations (Osei-Atweneboana et al., 2007).
A followed-up study was carried out to assess the adult worm re-
sponse to IVM by performing nodulectomies and embryogramme
analysis that showed further phenotypic evidence of emerging
IVM resistance in O. volvulus (Osei-Atweneboana et al., 2011). Here
we report a genetic analysis of the full length genomic DNA
sequence of the b-tubulin isotype 1 gene, showing evidence of
selection on this gene, consistent with the emergence of IVM resis-
tance in O. volvulus.2. Materials and methods
2.1. Epidemiological study
A 21 month epidemiological study was carried out in 10 oncho-
cerciasis endemic communities located in three districts in Ghana;
Kintampo and Atebubu districts in the Brong-Ahafo Region andGonja East district in the Northern region. The full details of the
study are described in Osei-Atweneboana et al. (2007) and
Osei-Atweneboana et al. (2011). Brieﬂy a total of 301 subjects
who were mf positive at the start of the study were selected from
nine IVM treated communities and one IVM naïve community.
With the exception of the IVM naïve community, all subjects had
received between 6 and 18 rounds of IVM treatments at the start
of the study. Before the commencement of the study, pretreatment
skin microﬁlaria proﬁles were assessed a week (day-7) before IVM
treatment. Serial mf assessments were carried out on days 30, 90,
180 and 364 after IVM treatment for the characterization of
parasitological responses, in terms of microﬁlarial clearance and
skin mf repopulation rates. A second IVM treatment was adminis-
tered 1 year after commencement of the study and nodulectomies
carried out 90 days after this second study IVM treatment. Ethical
approval was obtained from the Institutional Review Board of
Noguchi Memorial Institute for Medical Research, Ghana and
McGill University, Canada.
2.2. Nodulectomies and adult worm collection and embryogrammes
All subjects were examined for Onchocerca nodules by palpat-
ing the entire body, at day 90 after the second IVM treatment
(i.e. day 445 after ﬁrst study treatment). A total of 140 patients
selected from 10 endemic communities were prepared for nodu-
lectomies. Using local anesthesia, all palpable nodules were surgi-
cally removed from the patients. Nodules were digested using 0.5%
collagenase in a shaking water bath for 10–24 h, adult worms were
harvested and embryogrammes constructed on intact female
worms as described (Schulz-Key, 1988). Worms were stored at
80C until DNA extractions were carried out.
2.3. Classiﬁcation of IVM response categories in the 10 communities
We had previously classiﬁed the 10 communities into three IVM
response categories (poor IVM response category, intermediate
IVM response category, good IVM response category) and the
IVM naïve community (Osei-Atweneboana et al., 2011). The classi-
ﬁcation of the three IVM response categories was based on, (i) skin
microﬁlaria repopulation rates at days 90 and 180 post-IVM treat-
ment; (ii) skin mf recovery rate at 364 days post-IVM treatment;
(iii) nodule/worm viability and worm density; (iv) reproductive
activity (embryogrammes) of female worms; and (v) proportion
of individual subjects showing good or poor overall IVM response.
Four communities (Baaya, Beposo, Senyase and Hiampe) were clas-
siﬁed as good IVM response communities, two communities
(Asubende and Wiae) fell into the intermediate IVM response
category, and three communities (Kyingakrom, New Longoro and
Jagbenbendo) were classiﬁed as poor IVM response communities.
The fourth group is the previously IVM naïve community
(Begbomdo) which had no IVM treatment prior to the study and
served as the baseline response community. The naïve community
responded in a similar manner to the good response category.
The good IVM response category had virtually no mf repopula-
tion at day 90 post-IVM treatment (Osei-Atweneboana et al., 2007).
By day 180, mf repopulation rates were below 17% of pretreatment
mf densities. The skin mf recovery rates at 364 days post-IVM
treatment were less than the pre-IVM treatment mf densities
(<80% of pre-treatment mf densities). Worm density per nodule
was less than 0.5, embryogenesis had not resumed at 90 days after
IVM (Osei-Atweneboana et al., 2011). The IVM naïve community
was very similar to the good responders. However, very few of
nodules and worms were calciﬁed, individuals in this community
had high worm densities per nodule, as a result of only two expo-
sures to IVM, but skin mf recovery rate at 364 days after the ﬁrst
study IVM treatment was low (<42% of pre-treatment). For the
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90 post-IVM treatment was very low (< 4% of pre-treatment mf
density) or absent, at day 180 post-IVM treatment, mf repopulation
rate was up to 22% of pretreatment mf densities. The skin mf
recovery rates at 364 days post-IVM treatment was about 100%
of pre-IVM treatment mf densities and about 50% of nodules were
calciﬁed and worm density per nodule was close to one. Embryo-
genesis had resumed at 90 days after treatment in some worms
with up to 25% of worms producing intra-uterine mf. The poor
IVM response category had mf repopulation rates of up to 21% of
pre-treatment densities at 90 post-IVM treatment, and by day
180 post-IVM treatment, mf repopulation rates was up to 53.8%
of pretreatment mf densities. Skin mf recovery rates at 364 days
post-IVM treatment was above 110% of pre-IVM treatment mf den-
sities, few nodules were calciﬁed, worm density per nodule was
more than one and embryogenesis had resumed 90 days after
treatment with up to 40.6% of worms producing intra-uterine mf.
2.4. Onchocerca volvulus samples selected for genetic analysis
For each IVM response category, one or more communities were
selected from which O. volvulus nodules were taken for genetic
analysis of the adult worms. A total of 152 adult worms were
collected for genetic analysis; 50 worms from Kyingakrom (poor
IVM response), 44 worms from Begbombo (IVM naïve community),
26 worms from the Asubende (intermediate IVM response) and 32
worms from all communities in the good IVM response category
(made up of Baaya, Beposo, Senyase and Hiampe). Only small num-
bers of worms were obtained from each of these four communities
becausemost of the nodules andwormswere calciﬁed. Kyingakrom
was selected for the poor IVM response communities because it
showed the worse IVM response characteristics. Asubende was
selected for the intermediate IVM response category because it is
located close to the good response communities. In addition to
classifying the worms in terms of community IVM response catego-
ries, we also classiﬁed the worms based on IVM response of
individual subjects, regardless of community, into two groups: (i)
worms from good responding individuals, (ii) worms from poorly
responding individuals. The characteristics for classiﬁcation
according to the response of the individual host included, (i) mf
repopulation rates of >6 microﬁlariae/skin snip (mf/s) at days 90
and >20 mf/s at day 180 post-IVM treatment, (ii) high mf recovery
rates of greater than pre-treatment densities at day 364 post-IVM
treatment. In addition to coming from an individual host showing
a good or poor response according to these repopulation rates at
different intervals after treatment, female worms had embryo-
grammes constructed and the reproductive activity and output
determined (Osei-Atweneboana et al., 2011). Female worms, com-
ing from individual hosts that showed rapid repopulation with mf
and that were found to be reproductive active at 90 days post IVM
treatment were considered to have responded poorly to treatment.
2.5. DNA extraction, PCR ampliﬁcation and sequencing of full length
genomic DNA of O. volvulus b-tubulin isotype 1 gene
DNA was extracted from adult worms using the genomic DNA
isolation kit supplied by Qiagen Inc., Canada (DNeasy™ Tissue
Kit). Extraction was done for individual male and female worms
according to the manufacturer’s protocol.
The full length genomic DNA sequence of the b-tubulin isotype
1 gene of O. volvulus was ampliﬁed using nine sets of primer pairs
(Table 1). The genomic sequence of O. volvulus b-tubulin isotype
(GenBank Accession No. AF019886) has 3696 bp, consisting of 9
exons and 8 introns. Genomic DNA was extracted from each indi-
vidual worm from the three IVM response categories and the
previously IVM naïve community. For each sample the full lengthDNA of the b-tubulin gene was ampliﬁed. The general ampliﬁca-
tion conditions for the PCR were an initial denaturation at 95 C
for 3 min, followed by 35 cycles of 95 C for 45 s, an annealing tem-
perature of 55 C for 45 s, initial extension temperature at 68 C for
1 min and a ﬁnal extension at 68 C for 5 min. Modiﬁcations were
made to the annealing temperature depending on the primer pairs
and the amplicon length as shown in Table 1. Proof reading Taq
polymerase was used to avoid errors during PCR ampliﬁcation.
The PCR products obtained from all nine primer pairs were exam-
ined on a 1% agarose (TAE) gel electrophoresis at 110 V and visual-
ized using the Bio-Rad gel documentation system Gel Doc 2000,
and fragment sizes of all nine PCR products were conﬁrmed. Heat
shock protein 60 (hsp60) (GenBank No. AF121264), which was
known to be polymorphic from previous analyses (Eng et al.,
2006; Bourguinat et al., 2007) was also partially sequenced in
worms from the different communities and response categories.
A fragment of 376 bp of hsp60 containing a known polymorphic
site, was ampliﬁed by PCR from individual adult worms with the
primers 50-CAA TCA TGG GGA AGT CCA AAG-30 and 50-CTC AAA
ACC TTC CTT TGC AAT-30 at annealing temperature of 53 C. A high
ﬁdelity Platinum Taq DNA polymerase (Invitrogen) was used. The
amplicon included 100 bp of exonic, followed by 276 bp of intronic
sequence. The A/G polymorphism was located in the intron region.
All nine sets of PCR products of the full length genomic DNA
sequence of b-tubulin were sequenced directly at the McGill Uni-
versity/Genome Quebec Innovation Centre sequencing platform.
Sequences received were screened for sequencing errors by com-
paring the sequences with the accompanying chromatograms
and also with the O. volvulus b-tubulin reference DNA sequence
(GenBank No. AF019886). The sequences were analyzed and heter-
ozygosity determined using Sequencher™ 4.7 software (Gene Code
Corporation, Ann Arbor, MI 48108, USA). To avoid the effect of
background noise on heterozygosity, we only considered second-
ary peaks as signiﬁcant if they constituted at least 75% of the major
peak on the chromatogram. All SNPs site were examined to deter-
mine whether they were homozygous or heterozygous. After the
analysis of all the SNPs observed in the full length genomic DNA
sequence of O. volvulus, the SNPs sites showing signiﬁcant
(p < 0.05) differences were further considered.2.6. Statistical analysis
Pair-wise comparisons of SNP frequencies of worms from the
four IVM responses groups were carried out to determine the
differences in genetic changes in the b-tubulin gene. Chi-square
test was used for these analyses. However, for small sample sizes,
Fisher’s exact test was used. Differences in genotype and allele
frequencies between the four IVM response groups were also
determined. Also pair-wise comparisons of SNP frequencies were
performed to determine the difference between worms from
individual hosts showing good IVM responses and those showing
poor IVM responses.3. Results
The full length genomic DNA sequence (3696 bp) of b-tubulin
isotype 1 gene of O. volvulus was successfully ampliﬁed (Fig. 1). Of
152 worms that were ampliﬁed and sequenced, 127 worms (65
males and 62 female) produced good quality sequences for all 9
amplicons of the full length b-tubulin gene. From all the samples
sequenced and analyzed, we found 24 single nucleotide polymor-
phisms (SNPs) occurring at signiﬁcant frequencies and some
appeared to be associated with IVM selection. Seven SNPs occurred
in exons (3 in exon 2; 2 in exon 3; 2 in exon 7) and 17 SNPs in introns
or exon/intron junctions (5 in intron 1; 6 in intron 2; 2 in intron 3,
Table 1
Primer pairs for ampliﬁcation of full length genomic sequence of the b-tubulin gene in O. volvulus.
Primer pairs Annealing temperature (C) Region of genomic sequence ampliﬁed
*50-ATGAGAGAAATTGTTCATG-30 50-GAAATTCGAATTAAGAACTTC-30 50 2–747
*50-CAAAGTTGGAACTTCGAAG-30 50-CTCGAATGGAATCCATAGTA-30 52 665–1493
*50-ATATGTACCACGAGCAATC-30 50-CGATCCGGATATTCCTCACGA-30 51 1437–1856
*50-CATTTCGTAAATAATTCAGT-30 50-GTATCCACTCTAGACACTTG-30 49 1721–1999
*50-GTATGGGAACATTGTTGATC-30 50-GATTGAGATCGCCATAAGT-30 52 1809–2268
*50-GACATCTGCTTCCGAAC-3050-CAGCGAAAATCTTGATAGT-30 50 2214–2652
*50-CTTCGCACGTCTCTTAGT-30 50-GATGAATTCTTATTCTGCAC-30 52 2596–3079
*50-ATGATGCAAGTGCAGAATAAG-30 50-CATAAAGTATATCAGATGACG -30 51 3051–3350
*50-GATAATGGATGAATGTGAT-30 50-GCTTTTACTCTTCCTGTTC-30 50 3288–3644
* Sense primers.
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our samples, only one SNP in an exon caused a coding change, at po-
sition 320, from arginine (AGA) to lysine (AAA). When the frequen-
cies of the 24 SNPs were compared between the four IVM response
communities, signiﬁcant differences (p < 0.05) were found at eight
SNP sites in the b-tubulin gene (Table 2). The amplicon from the
control gene, hsp60, showed A/G polymorphism in an intron, but
there were no signiﬁcant differences between worms from the dif-
ferent IVM response communities. Further analyses were
conducted on the 6 SNPs showing the highest frequency for the
alternative nucleotide to that reported in the reference sequence
(GenBank No. AF019886). These SNPs were at 194 (A–T), 340 (C–
T), 1183 (T–G), 1188 (T–C), 1308 (C–T) and 1545 (A–G). The most
striking result was the genetic change observed at SNP position
1545 (A–G), which occurred at a signiﬁcantly higher frequency
(p < 0.0001) inworms from the poor IVM response community com-
pared with worms from the good IVM response communities and
the IVM naïve community. Also at the same site, 1545G occurred
more frequently (p < 0.05) in worms from the poor IVM response
community than O. volvulus from the intermediate response com-
munity (Asubende), while the latter also had a signiﬁcantly higher
(p 6 0.02) frequency thanworms fromboth the good response com-
munities and the IVM naïve community. This indicates that at theseFig. 1. Full length genomic sequence of b-tubulin isotype 1 gene of O. volvulus, showing e
and underlined are positions where SNPs were observed. Nucleotide with superscript m6 SNPs sites, the changes to the alternative nucleotide showed a
strong association with worms from the poor IVM response
community.
When we analyzed the response proﬁle of the 127 genotyped
adult worms, obtained from the four IVM response groups, for indi-
vidual host response to IVM treatment, 65.4% were obtained from
individual hosts showing good responses while 34.6% were
obtained from individual hosts showing poor responses. The geno-
typic analyses at the 6 SNP sites (194A/G, 340C/T, 1183T/G, 1188T/
C, 1308C/T and 1545A/G) on worms obtained from individual hosts
showing good responses to treatment (regardless of community)
indicated that 22% of the worms had the same genotype at these
6 SNP sites as the reference genomic sequence of b-tubulin which
had been cloned from worms not previously exposed to IVM
(Geary et al., 1998) and, overall, showed a very high degree of
sequence identity to the reference sequence. Several worms from
individual hosts showing good responses, from the IVM naïve com-
munity and the good IVM response community, showed 100%
homology to the reference sequence at all 6 SNP positions. For this
study, we have considered the reference sequence and worms hav-
ing the same homozygous genotype (194AA/340CC/1183TT/
1188TT/1308CC/1545AA) as wild type (WT). However, for most
of the worms from good responding individuals, we found thatxons (in bold and italics) and introns (regular). Nucleotides indicated in upper cases
arks the end of an exon and the exon number.
Table 2
Genetic analysis of full length genomic sequence of b-tubulin genotype isotype 1, showing frequencies at eight single nucleotide polymorphism (SNP) loci.
Ivermectin response/treatment community
category [no of worms analysed]
Frequencies of single nucleotide polymorphisms at genomic sequence positions of b-tubulin isotype 1
194, A/T% (n) 340, C/T% (n) 1183, T/G%
(n)
1188, T/C%
(n)
1308, C/T%
(n)
1545, A/G% (n) 2913, G/A%
(n)
3226, A/T%
(n)
A T C T T G T C C T A G G A A T
Previously naïve (Begbomdo) [42]
70.2
(59)
29.8
(25)b
41.7
(35)
58.3
(49)a
82.1
(69)
17.9
(15)d
72.1
(69)
17.9
(15)e
72.1
(69)
17.9
(15)d
77.4
(65)
22.6
(19)f
98.7
(79)
1.3
(1)c
95.2
(82)
4.8
(2)a
Good# [26]
82.6
(43)
17.3
(9)b
23.1
(12)
76.9
(40)a
90.4
(47)
9.6
(5)d
88.5
(46)
11.5
(6)e
88.5
(46)
11.5
(6)d
84.6
(44)
15.4 (8)f 98.1
(51)
1.9
(1)c
96.2
(51)
3.8
(1)a
Intermediate (Asubende) [16]
71.9
(23)
28.1
(9)b
25.0
(8)
75.0
(24)a
65.6
(21)
34.4
(11)
68.7
(22)
31.3
(10)
73.6
(23)
28.1
(9)d
56.2
(18)
43.8
(14)§f,a
90.6
(29)
9.4 (3) 94.0
(28)
6.0 (2)
Poor (Kyingakrom) [43]
46.5
(40)
53.5
(46)§b
9.3
(8)
90.7
(78)§a
57.0
(47)
43.0
(37)§d
52.2
(44)
48.8
(42)§e
56.9
(49)
43.1
(37)§d
38.4
(36)
61.6
(52)§f,§a
76.5
(52)
23.5
(16)§c
78.2
(61)
21.8
(17)§a
#Good response communities were Baaya, Beposo, Hiampe and Senyase. At each SNP position, a pair-wise comparison of the allele frequencies was carried out between all of
the four community categories. Signiﬁcant levels: §ap < 0.05 compared with a, §bp < 0.01 compared with b, §cp < 0.005 compared with c, §dp < 0.001 compared with d,
§ep < 0.0005 compared with e, §fp < 0.0001 compared withf.
The numbers in square parenthesis [X] indicate the number of worms analyzed, while the number in regular parentheses (X) indicate the number of each alternative
nucleotides at each SNP site for worms in each community category.
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cies, and 1183G and 1545G at moderate frequencies (p < 0.05).
The SNP 194A/T occurred mainly as homozygous AA in 63.1% of
worms, of which more than two thirds were from the IVM naïve
and good IVM response communities. Also the SNP 340C/T oc-
curred as homozygous TT or heterozygous CT in most worms from
all response communities. The genotype combinations of worms
from the good responding individuals show a total of 11 genotype
conﬁgurations at the four loci (194A/T, 340C/T, 1183T/G, 1545A/G),
termed WTA–WTK (Fig. 2). Thus the genetic proﬁles observed in
worms obtained from good responding individuals showed that
22% of the worms had the genotype WTA (AA/CC/TT/AA), 10.6%
the genotype WTB (AA/CT/TT/AA), 34.4% genotype WTC (AA/TT/
TT/AA) and 16.7% of the worms shared the three genotypes,
WTD, WTE, and WTF. The genotypes WTA, WTB and WTC occurred
mainly in worms from good responding individuals in the IVM
naïve community and good IVM response communities as well as
the intermediate response community. All 11 genotypes were
present in the IVM naïve community. However, three of these
genotypes were absent in worms from the good IVM response
communities while the moderate and poor IVM response commu-
nities did not have ﬁve of the genotypes found in the naïve
community.
The second set of worms analyzed were from the poor respond-
ing individual hosts in all four IVM response community groups,
comprising 34.6% of all worms genotyped. A comparison of worms
from the poorly responding individuals showed genetic changes at
4 SNPs sites 1183 T–G, 1188 T–C, 1308 C–T and 1545 A–G (see Ta-
ble 2 and Fig. 3) which were at signiﬁcantly higher frequencies
(p < 0.001) in the poor IVM response community (Kyingakrom)
than in the good IVM response communities and the IVM naïve
community. Also the genetic change occurring at SNP site 1188
T/C was found to be usually linked with changes at SNP site
1183T/G, 1308C/T and 1545A/G occurring mostly as homozygotes.
This suggested that the genetic changes occurring at these SNPs
sites are strongly associated with poor IVM responses at both the
community and individual host levels.
Considering the possible combinations at these four loci, one
could expect up to 48 possible conﬁgurations for the genotypes.
However, because of possible linkage between some of the loci,
we found only seven genotypes conﬁgurations in the worms from
poorly responding individuals, which we have termed, RT1–RT7(Fig. 3). Table 3 summarizes the proportion ofworms showing geno-
type (wild type sequence) associated with good response (WTA–
WTK), or genotype associated with poor response (RT1–RT7) in
individuals hosts classiﬁed as showing good or poor phenotypic re-
sponses. We found different levels of genotype association with
worms frompoorly responding individuals in the four IVM response
categories. The genotype conﬁguration RT7, represented by GG/CC/
TT/GG showed a strong association (p < 0.01) with nearly 40% of
worms from the poor IVM response community (Kyingakrom) hav-
ing this genotype. In the IVM naïve community, all the genotypes
(RT1–RT7) occurred at low frequencies. In the good IVM response
communities, RT7 was absent, but other genotypes RT2, RT3 and
RT5were present at low frequencies. Four genotypic conﬁgurations
were found in the intermediate response community, with RT7
occurring at a frequency of 12.5%. The absence of some genotypes
in the intermediate response community may possibly be due to
the small sample size. Alsoworms from the poor IVM response com-
munity had six genotypes, ﬁve occurred at frequencies of 2.3–10%.
Considering all the worms from poorly responding individuals in
all four community categories, we found that almost half theworms
from the poorly responding individuals had the genotype RT7, and
out of these, 78% were from the poor IVM response community
(Kyingakrom).
To determine the correlation between the worm genotypes and
phenotypes, comparisons were made between the worm geno-
types RT1–RT7 and the phenotypic characteristics of worms ob-
tained from the poorly responding individuals as well as the IVM
response categories. The phenotypic characteristics included mf
repopulation rates and female worm embryogrammes. For the
genotypes, RT1–RT6, we did not ﬁnd strong associations with the
worm or host phenotypic response characteristics. However, the
association between RT7 frequency and the poor response pheno-
type of the worm and host mf repopulation was very pronounced.
Worms from individuals with mf repopulation at day 90 post IVM
treatment, mf recovery rates of greater than pre-treatment densi-
ties at day 364 post-IVM treatment and female worms that were
reproductively active 90 days after treatment had a strong associ-
ation (p < 0.01) with the genotype RT7. Furthermore, there were
other genetic changes at positions 1093 (C–T), 1298 (T–C), 2913
(G–A) and 3226 (A–T), but these occurred at relatively moderate
frequencies and predominantly in poorly responding individuals.
More than 87% of these changes were found in worms in the poor
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netic change of importance occurred at genomic position 2754 cor-
responding to the amino acid at position 320 of the protein
sequence. The SNP (AAA–AGA) resulted in a change from arginine
to lysine. This change occurred at a frequency of 5% in worms from
poorly responding individuals and interestingly, worms carrying
320Lys also had the RT7 genotype and mostly female worms with
these genetic changes were reproductively active at day 90 post
IVM treatment.
4. Discussion
Anthelmintic resistance is a heritable phenomenon resulting
from changes in the genetic proﬁle of a parasite population that
subsequently leads to a phenotype of a reduced response to treat-
ment. Drug resistance involves changes in genes and their pro-
teins that can result in mechanisms of resistance. However,
some genetic changes may not themselves be the cause of resis-
tance mechanisms, but be linked to other genes whose products
are associated with resistance mechanisms. In veterinary nema-
todes, genes for P-glycoprotein (Xu et al., 1998), b-tubulin (Mot-
tier and Prichard, 2008), glutamate chloride channels (GluCls)
(Njue et al., 2004) and gamma-amino butyric acid receptor sub-
units (Blackhall et al., 2003) have been reported to be associated
or involved in IVM selection and resistance. In O. volvulus, genetic
selection has been found in b-tubulin in populations under
repeated IVM treatments (Eng and Prichard, 2005; Eng et al.,
2006; Bourguinat et al., 2007). To further explore and elucidate
the involvement and importance of the b-tubulin gene in genetic
selection and resistance to IVM and also for possible development0
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this gene in O. volvulus obtained during the epidemiological study
by Osei-Atweneboana et al. (2007) and further study by
Osei-Atweneboana et al. (2011). This study provided excellent
material for this genetic analysis, because O. volvulus adult worms
were obtained from hosts and parasites that were characterized
in terms of the IVM response phenotype; this makes our study
unique. Furthermore, in contrast to previous studies, the genetic
analysis was carried out on the whole b-tubulin gene. Eight out
of the 24 SNPs found in both the introns and exons show genetic
changes that provided signiﬁcant associations with the response
phenotype. Worm genotypes from individuals showing good
IVM responses were predominantly the wild type (WT) geno-
types: WTA, WTB and WTC, which we have considered as suscep-
tible genotypes. A similar but much stronger association was
observed in worm genotypes from individuals showing poor
IVM responses. We found seven genotypes (RT1–RT7) at four loci
(1183T/G, 1188T/C, 1308C/T and 1545A/G). Two of the SNPs
(1188T–C, and 1308 C–T) were strongly linked. In addition, they
mostly occurred together with the two other SNPs (1183T/G
and 1545A/G) found in the RT genotypes. These RT genotypes
showed a signiﬁcant association (p < 0.05) with worms obtained
from individuals showing poor IVM responses. A further compar-
ative analysis of the RT genotypes with worm phenotypes from
individuals showing poor IVM responses revealed a stronger asso-
ciation with RT6 and RT7 genotypes. We consider RT6 and RT7
genotypes as resistance genotypes (RT) and the worms associated
with these genotypes as resistance phenotype. The presence of a
few resistance genotype worms in the IVM naïve community
(Fig. 3) is not surprising, because it has been suggested thatT/TT/AA
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Fig. 3. Genotype frequencies in the b-tubulin gene in worms from individuals showing poor IVM response from the four community categories. Four SNPs found at genomic
positions 1183 (T–G), 1188 (T–C), 1308 (C–T) and 1545 (A–G) appeared to be linked with poor response in individual hosts. Only seven genotype conﬁgurations were found in
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anthelmintic-naive populations, but at low frequencies (Kelly
et al., 1978; Prichard et al., 1980; Jackson, 1993) and that IVM
resistance probably occurs through the selection of existing
alleles present in the population (Anderson et al., 1998).
The most interesting genotype, RT7 (GG/CC/TT/GG), was homo-
zygous for all the alternate nucleotides and showed the strongest
association (p < 0.002) with the resistance phenotype worms, at a
frequency of 39.5% in the poor IVM response community (Kyinka-
grom). It must be emphasized that RT7 was found predominantly
in female worms that were reproductively active at day 90 post-
IVM treatment and in male worms from the same individuals
and also from individual hosts that had high mf repopulation rates
at day 90 and/or high mf recovery rates at day 364 post-IVM treat-
ment. We see the presence of RT7, together with the other geno-
types (RT1–RT6) in the poor IVM response community as
possible markers for the emergence of IVM resistance in O.
volvulus.
The loss of ﬁve ‘susceptibility’ genotypes and reduction in
frequencies of other genotypes observed in the poor IVM
response community suggests that in these communities, IVM
has selected against worms carrying ‘susceptibility’ genotypes
and allowed worms carrying the ‘resistance-associated’ genotype
RT7 to continue to reproduce, contributing their gene pool to the
next generation (Prichard et al., 1980). Eng and Prichard (2005)
have previously reported two b-tubulin alleles, and observed that
IVM had selected for one of these b-tubulin alleles while the
other allele predominated in IVM naïve populations. The treat-
ment-associated allele was distinguished from allele predominant
in the naïve population by having three amino acid changes
(Met117Leu, Val120Ile and Val124Ala) in the coding region anda 24 bp intronic deletion. In another study, Eng et al. (2006) found
the absence or very low frequency of the treatment-associated
allele in O. volvulus samples obtained in 1989/90, before the
widespread introduction of IVM for onchocerciasis, but moderate
frequencies of the treatment-associated allele in samples
obtained, in Ghana, 8 years after widespread use of IVM, with
the frequency being highest in communities which had been un-
der annual treatment for 3–8 years. They also observed a higher
frequency of the ‘treatment-associated’ allele in samples of micro-
ﬁlaria obtained from people who had responded sub-optimally to
IVM, and had proposed the possibility that the more IVM tolerant
adult worms, which were presumable homozygous or heterozy-
gous for the ‘treatment-associated’ allele would be responsible
for passing on this allele to their microﬁlaria progeny and there-
fore the frequency of the treatment-associated allele could in-
crease in the microﬁlariae with repeated rounds of treatment.
Surprisingly, in our current study in Ghana, we observed in all
communities, O. volvulus populations had these three amino acid
changes (117Leu, 120Ile and 124Ala) at 100% frequency, suggest-
ing that two decades of IVM treatment in Ghana had already ex-
erted marked selection on the b-tubulin gene regardless of
whether the response to treatment still appeared to be good or
was poor. While the treatment naïve community had itself not
been under IVM treatment prior to the study a great portion of
the onchocerciasis endemic regions of Ghana, including districts
close to the naïve community, have been under IVM treatment
for many years. Nevertheless, it is perhaps difﬁcult to explain this
apparently rapid genetic transition in O. volvulus populations in
Ghana, given the long life span of this parasite. However, it
may be due to the fact that strong IVM selection pressure on O.
volvulus has been ongoing for two decades leading to a relatively
Table 3
The association between worm b-tubulin genotypes and IVM response in individual hosts.
IVM
response
category/
community
% (n) of
subjects
showing
poor
response
to IVM
No. of
worms
genotyped
% (n) of
worms
from
individuals
showing
good
response to
IVM
% (n) of
worms
from
individuals
showing
poor
response to
IVM
Genotypic analysis of worm
from individuals showing good
IVM response
Genotypic analysis of worms
from individuals showing poor
IVM response
Total% (n) of
worms
having
genotype
associated
with poor
response in
host (RT1–
RT7)
% (n) of
worms
having the
most marked
genotype
associated
with resistant
phenotypes
(RT7)
% (n) of worms
showing
genotype (wild
type sequence)
associated with
good response
in host (WTA–
WTK)
% (n) of
worms
showing
genotype
associated
with poor
response in
host (RT1–
RT7)
% (n) of worms
showing
genotype (wild
type sequence)
associated with
good response
in host (WTA–
WTK)
% (n) of
worms
showing
genotype
associated
with poor
response in
host (RT1–
RT7)
Previously
naive
10.8 (4) 42 85.7 (36) 14.3 (6) 78.6 (33)§b 7.1 (3) 4.8 (2) 7.1 (4) 16.7 (7)c 4.8 (2)a
Good 8.8 (5) 26 84.6 (22) 15.4 (4) 84.6 (21)§b 3.8 (1) 7.7 (1) 11.5 (3) 15.4 (4)c 0a
Moderate 33.3 (4) 16 62.5 (10) 37.5 (6) 44.0 (8) 18.5 (2) 12.5 (2) 25.0 (4) 37.5 (6) 12.5 (2)a
Poor 66.7 (18) 43 34.8 (15) 65.1 (28) 27.9 (12)b 6.9 (3) 11.6 (2) 53.5 (26) 67.4 (29)§c 39.5 (19)§a
The four community categories were compared for the proportion of worms associated with a particular genotype (WT or RT). Signiﬁcant levels: §ap < 0.05 compared with a,
§bp < 0.02 compared with b, §cp < 0.01 compared with c.
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selection for a resistance genotype. These changes, coupled with
the selection for genotypes such as RT7 may indicate that a resis-
tance genotype has already emerged, and that the RT7 genotype
can be used to monitor for resistance.
The recent reports of sub-optimal responses and emergence of
IVM resistance in O. volvulus (Ali et al., 2002; Awadzi et al.,
2004a,b; Osei-Atweneboana et al., 2007, 2011), coupled with the
fact that IVM has been used for over two decades and remains
the only drug available for treatment of onchocerciasis makes the
need to monitor for possible IVM resistance in O. volvulus of great
importance. Ali and co-workers reported that the subjects showing
sub-optimal O. volvulus responses to IVM had reduced proliferative
responses to Onchocerca antigens and speculated that the sub-
optimal responses may be due to host immunocompetence. Cre-
dence for this hypothesis could be drawn from the recent observa-
tion that in Brugia malayi mf, a glutamate-gated chloride channel
(GluCl) receptor was localized only to the excretory pore and that
in the mf, IVM reduced the secretion of protein from the mf
(Moreno et al., 2010). These authors speculated that the excretory
pore is the main source of excretory/secretory protein from the mf
and that components of this secreted protein may regulate the lo-
cal immune response to the mf, so that a diminution in the level of
secretion, caused by IVM action on the excretory pore GluCl, could
render ﬁlarial mf susceptible to immune killing. A similar effect of
IVM only on the excretory pore leading to an inability of the para-
site to modulate the local immune response in the host has not
been shown for adult worms. In the sub-optimal responses ob-
served in subjects infected with O. volvulus in Ghana, killing of
mf was not affected (Osei-Atweneboana et al., 2007). On the other
hand, the production of mf by the adult worms and the return of
fertility in the adult worms was altered (Osei-Atweneboana et al.,
2011) in a manner similar to that observed earlier (Awadzi et al.,
2004a). It should also be noted that other than the possibility of
an immune involvement in the sub-optimal responses observed
in Sudan (Ali et al., 2002), there are no other reports that the im-
mune status in humans affects the response of O. volvulus to
IVM, and in particular the repopulation rate of skin mf. In addition,
an investigation of O. volvulus responses to IVM in HIV patients
showed no diminution in the effect of treatment (Fischer et al.,
1995).
As an alternative explanation for the high skin microﬁlarial
repopulation rates, it has been postulated that there may have been
repeated re-infections due to poor drug coverage in the studycommunities and in surrounding communities (Remme et al.,
2007). A high proportion of young adult worms could indeed lead
to high skin mf counts as was found in the pre-study IVM-naive
community (21% of worms were young adults in this community;
Osei-Atweneboana et al., 2011), where obviously coverage was
non-existent prior to this study. However, all of the communities
categorized as poor or intermediate responders had good records
of treatment coverage. While treatment coverage in some commu-
nities in the East Gonja district (where the pre-study treatment
naive community is found) may have been poor, coverage in
surrounding communities in the Atebubu and Kintempo districts
where the poorly responding Kyingakrom and New Longoro com-
munities are located, was generally good (Osei-Atweneboana and
Prichard, unpublished). The mechanism underlying the proposed
hypothesis that poor coverage could explain the sub-optimal
responses, is that recruitment of signiﬁcant numbers of new adult
worms would account for the higher than expected skin mf load.
However, the embryogrammes from the multi-dosed communities
showed a dearth of young adult worms at a modest level of repro-
ductive activity. These ﬁndings do not support a hypothesis that
the sub-optimal responses were due to poor treatment coverage,
nor does the analysis of the annual transmission rate that would
be required to account for the skin mf repopulation rates observed
in the poor responder communities (Churcher et al., 2009). It is also
of interest that in the example of poor coverage, in the treatment na-
ive community, the recovery rate of skin mf count 364 days after
IVM treatment was only 41.6% of pre-treatment mf count, in con-
trast to the situation seen in the poor responder communitieswhere
the recovery rateswere allwell in excess of 100% of pretreatmentmf
counts (Osei-Atweneboana et al., 2011). It also needs to be noted
that for the 2 study IVM doses, treatment of each individual subject
was observed by the study team, and elimination ofmf 30 days after
treatment, and a marked reduction in skin mf 90 days after treat-
ment, were observed. Therefore, one can be certain that the subjects
responding poorly to IVM treatment, in terms of rate of skin mf
repopulation and embryogrammes, were treated twice in the study
and that poor coverage cannot explain the sub-optimal responses.
Resistance in O. volvulus can be deﬁned as either a reduction in
the duration of the anti-fecundity effect of IVM on adult O. volvulus
or a reduction in themicroﬁlaricidal effect of IVM (Grant, 2000). The
evidence of marked phenotypic and genotypic differences between
the poorly responding communities/individuals and parasites, com-
paredwith the naïve and good responding communities/individuals
and parasites lead us to a conclusion that selection for resistance is
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of resistance is in the shortening of the anti-fecundity effect of IVM.
We concur with the suggestion of Grant (2000) that this manifesta-
tion of resistance could be more serious for the onchocerciasis
control programs, because it enables resistant worms to breed and
be transmitted formost of the year, than a reduction in themicroﬁl-
aricidal effects alone.
Monitoring for resistance in O. volvulus should be undertaken as
part of onchocerciasis control programs because once resistance
reaches phenotypically-detectable levels, irreversible changes in
the genetic structure of the worm population may have already
occurred. Since there is still no alternative chemotherapeutic agent
for mass treatment of onchocerciasis, it is highly desirable that IVM
can continue to be used for a long time to control the disease. Sus-
taining the efﬁcacy of the drug for as long as possible requires the
development of sensitive molecular markers that can detect
emerging resistance at its early stage. This then can be used for
routine surveillance to monitor for resistance in order to prevent
the spread of resistance genotypes. The identiﬁcation of these spe-
ciﬁc genetic changes that are linked with IVM resistance pheno-
types should be very useful. The study suggests that the genetic
changes occurring at genomic positions 1183T/G, 1188T/C,
1308C/T and 1545A/G, and especially the genotype RT7 (GG/CC/
TT/GG) make good candidate markers for resistance surveillance.
Moreover, since these SNPs occur within a region of 362 bp, it will
be entirely practical to use this region of b-tubulin gene to develop
a DNA assay for early detection and monitoring for IVM resistance.
Initial monitoring for possible IVM resistance, as part of IVM distri-
bution programs, could be conducted using a genetic marker on
the larval stages of the parasite found in vectors.
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